Xtant Medical Holdings, Inc. (XTNT)
- Previous Close
0.7844 - Open
0.8170 - Bid --
- Ask --
- Day's Range
0.7935 - 0.8788 - 52 Week Range
0.6000 - 1.4500 - Volume
74,084 - Avg. Volume
154,445 - Market Cap (intraday)
109.018M - Beta (5Y Monthly) 0.22
- PE Ratio (TTM)
83.72 - EPS (TTM)
0.0100 - Earnings Date May 2, 2024 - May 6, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
1.93
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons. It offers OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSelect DBM Putty to mold into any shape and compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, a growth factor enriched cellular bone matrix; and nanOss family of products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, it offers Certex spinal fixation, Spider cervical plating, Streamline OCT, CervAlign, Axle interspinous fusion, Xpress minimally invasive pedicle screw, Fortex pedicle screw, Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation systems, and Silex sacroiliac joint fusion systems. Further, it provides Calix for cervical and thoracolumbar applications, as well as Irix-C Cervical Integrated Fusion, Irix-A Lumbar Integrated Fusion, Fortilink, and Irix-A Lumbar integrated fusion systems; Coflex device for lumbar spinal stenosis; and CoFix implant for back and disc pain. The company is headquartered in Belgrade, Montana.
www.xtantmedical.comRecent News: XTNT
Performance Overview: XTNT
Trailing total returns as of 4/18/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: XTNT
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: XTNT
Valuation Measures
Market Cap
109.02M
Enterprise Value
126.86M
Trailing P/E
83.72
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.16
Price/Book (mrq)
2.12
Enterprise Value/Revenue
1.39
Enterprise Value/EBITDA
25.00
Financial Highlights
Profitability and Income Statement
Profit Margin
0.72%
Return on Assets (ttm)
-8.31%
Return on Equity (ttm)
1.54%
Revenue (ttm)
91.3M
Net Income Avi to Common (ttm)
660k
Diluted EPS (ttm)
0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
5.71M
Total Debt/Equity (mrq)
45.88%
Levered Free Cash Flow (ttm)
-25.38M
Research Analysis: XTNT
Analyst Price Targets
Fair Value
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell